Procalcitonin as a diagnostic test for sepsis: Health technology assessment in the ICU

Journal of Critical Care

Volumn 18, Issue 1, 2003, Pages 52-58

  Gattas, David J ^a   Cook, Deborah J ^b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROCALCITONIN;

CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; HUMAN; INTENSIVE CARE; LABORATORY TEST; MEDICAL DECISION MAKING; PATIENT ATTITUDE; PROTEIN BLOOD LEVEL; RELIABILITY; SEPSIS; STATISTICAL MODEL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0037344246     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1053/jcrc.2003.YJCRC11     Document Type: Conference Paper

References (38)

1. Jacobs JW, Lund PK, Potts JT Jr, et al: Procalcitonin is a glycoprotein. J Biol Chem 256:2803-2807, 1981
2. Le Moullec JM, Jullienne A, Chenais J, et al: The complete sequence of human preprocalcitonin. FEBS Lett 167:93-97, 1984
3. Broad PM, Symes AJ, Thakker RV, et al: Structure and methylation of the human calcitonin/alpha-CGRP gene. Nucleic Acids Res 17:6999-7011, 1989
4. Assicot M, Gendrel D, Carsin H, et al: High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341:515-518, 1993
5. Jaeschke R, Guyatt G, Sackett DL: Users' guides to the medical literature. III. How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA 271:389-391, 1994
6. Keenan SP, Guyatt GH, Sibbald WJ, et al: How to use articles about diagnostic technology: Gastric tonometry. Crit Care Med 27:1726-1731, 1999
7. Jaeschke R, Guyatt GH, Sackett DL: Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA 271:703-707, 1994
8. Jaeschke RZ, Meade MO, Guyatt GH, et al: How to use diagnostic test articles in the intensive care unit: Diagnosing weanability using f/Vt. Crit Care Med 25:1514-1521, 1997
9. Guyatt GH, Tugwell PX, Feeny DH, et al: A framework for clinical evaluation of diagnostic technologies. CMAJ 134: 587-594, 1986
10. HTA-Checklist: International network of agencies for health technology assessment [On-line]. Available: www. inahta.org. Accessed: December 15, 2002
11. Canadian Coordinating Office for Health Technology Assessment: Authors' guides [On-line]. Available: www. ccohta.org. Accessed: December 15, 2002
12. Bone RC, Balk RA, Cerra FB, et al: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644-1655, 1992
13. Bernard GR, Vincent JL, Laterre PF, et al: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699-709, 2001
14. van den Berghe G, Wouters P. Weekers F, et al: Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359-1367, 2001
15. Annane D, Sebille V, Charpentier C, et al: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862-871, 2002
16. Vincent JL: Dear SIRS, I'm sorry to say that I don't like you. Crit Care Med 25:372-374, 1997
17. Pugin J: Biomarkers of sepsis: Is procalcitonin ready for prime time? Intensive Care Med 28:1203-1204, 2002
18. Vincent JL: Procalcitonin: The marker of sepsis? Crit Care Med 28:1226-1228, 2000
19. Bohuon C: A brief history of procalcitonin. Intensive Care Med 26:S146-S147, 2000
20. Kretzschmar M, Kruger A, Schirrmeister W: Procalcitonin following elective partial liver resection - origin from the liver? Acta Anaesthesiol Scand 45:1162-1167, 2001
21. Nijsten MW, Olinga P, The TH, et al: Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med 28:458-461, 2000
22. Ghillani PP, Motte P, Troalen F, et al: Identification and measurement of calcitonin precursors in serum of patients with malignant diseases. Cancer Res 49:6845-6851, 1989
23. Nylen ES, Whang KT, Snider RH Jr, et al: Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med 26:1001-1006, 1998
24. Wagner KE, Martinez JM, Vath SD, et al: Early immunoneutralization of calcitonin precursors attenuates the adverse physiologic response to sepsis in pigs. Crit Care Med 30:2313-2321, 2002
25. Meisner M: Procalcitonin (PCT), 3rd ed. Stuttgart, Georg Thieme Verlag, 2000
26. Meisner M, Tschaikowsky K, Schnabel S, et al: Procalcitonin - influence of temperature, storage, anticoagulation and arterial or venous asservation of blood samples on procalcitonin concentrations. Eur J Clin Chem 35:597-601, 1997
27. Gendrel D, Raymond J, Assicot M, et al: Measurement of procalcitonin levels in children with bacterial or viral meningitis. Clin Infect Dis 24:1240-1242, 1997
28. Gendrel D, Assicot M, Raymond J, et al: Procalcitonin as a marker for the early diagnosis of neonatal infection. J Pediatr 128:570-573, 1996
29. Aouifi A, Piriou V, Bastien O, et al: Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients. Crit Care Med 28:3171-3176, 2000
30. Harbarth S, Holeckova K, Froidevaux C, et al: Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 164:396-402, 2001
31. Selberg O, Hecker H, Martin M, et al: Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Crit Care Med 28:2793-2798, 2000
32. Giamarellos-Bourboulis EJ, Mega A, Grecka P, et al: Procalcitonin: A marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient? Intensive Care Med 28:1351-1356, 2002
33. Ruokonen E, Ilkka L, Niskanen M, et al: Procalcitonin and neopterin as indicators of infection in critically ill patients. Acta Anaesthesiol Scand 46:398-404, 2002
34. Suprin E, Camus C, Gacouin A, et al: Procalcitonin: A valuable indicator of infection in a medical ICU? Intensive Care Med 26:1232-1238, 2000
35. Ugarte H, Silva E, Mercan D, et al: Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 27:498-504, 1999
36. Wanner GA, Keel M, Steckholzer U, et al: Relationship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med 28:950-957, 2000
37. Fagan TJ: Nomogram for Bayes's theorem. N Engl J Med 293:257, 1975
38. McGee S: Simplifying likelihood ratios. J Gen Intern Med 1:647-650, 2002